What is NVAX's current stock price?

As of now, NVAX is trading at $5.48, with a daily change of -18.89%.

What are NVAX stock strengths?

NVAX strengths include Investors confidence is positive, .

What are the risks associated with NVAX stock?

NVAX Key risk is its Extreme Risk Level, .

What is NVAX next earnings date?

NVAX next earnings report is scheduled for May 8, 2025 .

What is NVAX's current stock rating?

NVAX's current stock rating is Buy.

Should I buy NVAX stock right now?

Based on the current rating of Buy, it is advisable to consider Buy as your next step with NVAX stock.

Is NVAX a Strong Buy right now?

NVAX's current stock rating is Buy, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for NVAX?

A 'Strong Buy' rating for NVAX indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for NVAX?

A 'Strong Sell' rating for NVAX suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence NVAX's stock rating?

NVAX's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Novavax (NVAX) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

NVAX

Novavax

$5.48

-$1.27 | -18.89%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

Open

$ 6.41

MKT CAP

$ 879.82M

High

$ 6.49

VOL

$ 17.56M

Low

$ 5.01

AVG VOL

$ 4.85M

Chart

7.87

8.53

8.72

3.95

1year

6month

3month

1month

NVAX Latest Headlines +

Novavax in selloff after RFK Jr.s comments on COVID vaccine.

Today

Momentum

Novavax stock tumbles on HHS comments about vaccine.

Today

Momentum

Novavax (NVAX) Soars 11.4%: Is Further Upside Left in the Stock?. Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Mon Apr 7, 2025

Momentum

Potential

Novavax (NVAX) Stock Sinks As Market Gains: Heres Why. In the latest trading session Novavax (NVAX) closed at $5.98 marking a -0.33% move from the previous day.

Wed Apr 2, 2025

Momentum

FDA Delays Full Approval Decision On Novavaxs COVID-19 Vaccine. In September 2024 the United States Food And Drug Administration (FDA) granted Emergency Use Authorization to) COVID-19 Vaccine Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in.Novavax'.s vaccine was included in the recommendations issued by the United States Centers for Disease Control and Prevention (CDC) onJune 27 2024.According to a media report on Wednesday the regulators missed th

Wed Apr 2, 2025

Activity

Novavax bid for full approval of COVID vaccine stymied by FDA - report.

Wed Apr 2, 2025

Activity

Novavax shares fall after FDA delays vaccine approval.

Wed Apr 2, 2025

Activity

Momentum

Novavax Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It. Recently Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Mon Mar 31, 2025

Activity

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.. Shares of Moderna Novavax and other biotech companies fell after FDA official Peter Markss resignation in protest of Robert F. Kennedy Jr.

Mon Mar 31, 2025

Activity

Moderna Novavax Shares Are Sliding Wednesday: Whats Going On?. Vaccine makers ) and ) are facing selling pressure on Wednesday following reports suggesting the Trump administration will .report The Trump administration plans to cease financial support for vaccine alliance Gavi which helps buy vaccines for children in developing countries. The Trump administration is also planning to “.significantly scale back”. support for efforts to combat malaria the report ...

Wed Mar 26, 2025

Activity

Momentum

Explore our NVAX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVAX Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVAX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

NVAX

Novavax

$5.48

-$1.27 | -18.89%

Chart

7.87

8.53

8.72

3.95

1year

6month

3month

1month

Discover NVAX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVAX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVAX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVAX Stock trends

NVAX Stock performance

NVAX Stock analysis

NVAX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

NVAX Stock Analysis for the Last 90 Days

NVAX Risk Level

NVAX Analysts Opinion

NVAX Street Consensus

NVAX Performance Sentiment

Technical Price Levels

NVAX Financial Health

Explore our NVAX Stock insights

Receive our NVAX Daily Alerts

NVAX Stock Analysis for the Last 90 Days

NVAX Street Consensus

Technical Price Levels

Discover NVAX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVAX. We're here to help you make informed investment decisions today.

Receive our NVAX Daily Alerts